Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3

Abstract

We studied loss of heterozygosity (LOH) on human chromosome 13q in prostate cancer specimens to determine the location of a putative tumor suppressor gene (TSG) and to correlate these losses with the clinicopathological stage of the disease. Overall 13 (21%) of 61 specimens analysed had an allele loss on the long arm of chromosome 13. The most frequent (37%) LOH among the informative cases with allele losses was detected at the D13S284 locus on chromosome 13q14.3. A portion of the DNA segment that spans this locus and is flanked by the microsatellite loci D13S153 and D13S163 was lost in 85% of the specimens with allele losses and was designated as a LOH cluster region (LCR). The LCR spans more than 6 Mbp of DNA. The results suggest that a TSG relevant for the development of prostate cancer is located telomeric to the RB locus. There was a significant correlation (P=0.0024) between chromosome 13q LOH and advanced metastatic disease, suggesting that loss of 13q14.3 region is associated with prostate cancer progression. However, further research must be conducted to establish the identity and function of this putative TSG.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Bergerheim US, Kunimi K, Collins VP and Ekman P. . 1991 Genes, Chromosomes Cancer 3: 215–220.

  • Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle EW and Lee WH. . 1990 Proc. Natl. Acad. Sci. USA 87: 7762–7766.

  • Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC and Issacs WB. . 1993 Cancer Res. 53: 3869–3873.

  • Brewster SF, Browne S and Brown KWZ. . 1994 J. Urol. 151: 1073–1077.

  • Brooks JD, Bova GS and Issacs WB. . 1995 Prostate 26: 35–39.

  • Brooks JD, Bova SG, Ewing CM, Piantadosi S, Carter BS, Robinson JC, Epstein JI and Issacs WB. . 1996 Cancer Res. 56: 3814–3822.

  • Brown AG, Ross FM, Dunne EM, Steel CM and Weir-Thompson EM. . 1993 Nat. Genet. 3: 67–72.

  • Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Issacs PW, Bova SG and Sidransky D. . 1997 Cancer Res. 57: 4997–5000.

  • Carter BS, Ewing CM, Ward WS, Treioger BF, Aalders TW, Schalken JA, Epstein JI and Isaacs WB. . 1990 Proc. Natl. Acad. Sci. USA 87: 8751–8755.

  • Collins A, Frezal J, Teague J and Morton NE. . 1996 Proc. Natl. Acad. Sci. USA 93: 14771–14775.

  • Cooney KA, Wetzel JC, Merajver SD and Macoska JA. . 1996 Cancer Res. 56: 1142–1145.

  • Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S, Jenkins RB, Bostwick DG and Thibodeau SN. . 1996 Cancer Res. 56: 4475–4482.

  • Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Sebon E, Lathrop M, Gyapay G, Morissette J and Weissenbach J. . 1996 Nature 380: 152–154.

  • Fleming ID, Cooper JS, Henson DE, Huntter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH and Yarbro JW (eds). . 1997 AJCC Cancer Staging Manual, 5th edition Lippincott-Raven, Philadelphia: New York.

    Google Scholar 

  • Gleason D. . 1977 Urologic Pathology: The prostate. Tannenbaum M (ed.).. Lea & Febiger: Philadelphia pp. 171–197.

    Google Scholar 

  • Gudmundsson J, Johannesdottir ZG, Bergthorsson JT, Aaronson A, Ingvarsson S, Egilsson V and Barkardottir RB. . 1995 Cancer Res. 55: 4830–4832.

  • Kagan J, Stein J, Babaian RJ, Joe Y, Pisters LL, Glassman AB, von Eschenbach AC and Troncoso P. . 1995 Oncogene 11: 2121–2126.

  • Kerangueven F, Allione F, Noguchi T, Adelaide J, Sobol H, Jacquemier J and Birinbaum D. . 1995 Genes, Chromosomes Cancer 13: 291–294.

  • Kunimi K, Bergerheim USR, Larsson IL, Ekman P and Collins VP. . 1991 Genomics 11: 530–536.

  • Landis SH, Murray T, Bolden S and Wingo PA. . 1999 CA: Cancer J. Clin. 4: 8–31.

  • Latil A, Baron JC, Cussento O, Fournier G, Soussi T, Boccon-Gbod L, Le Duc A, Rouse J and Lidereau R. . 1995 Bulletin de Cancer 82: 589–597.

  • Li C, Larsson C, Futreal A, Lancaster J, Phelan C, Aspenblad U, Sundelin B, Liu Y, Ekman P, Auer G and Bergerheim USR. . 1998 Oncogene 16: 481–487.

  • Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Itterman M, Tycko B, Hibshoosh H, Wigler MH and Parsons R. . 1997 Science 275: 194–197.

  • Liu Y, Corcoran M, Rasool O, Ivanova G, Ibbotson R, Grander D, Iyengar A, Baranova A, Kashuba V, Merup M, Wu X, Gardiner A, Mullenbach R, Poltaraus A, Hultstrom AL, Juliusson G, Chapman R, Tiller M, Cotter F, Gahrton G, Yankovsky N, Zabarovsky E, Einhorn S and Oscier D. . 1997 Oncogene 15: 2463–2473.

  • MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D and Bookstein R. . 1994 Genes, Chromosomes Cancer 10: 151–159.

  • Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietruk T and Powell IJ. . 1995 Cancer Res. 55: 5390–5395.

  • Mastero R, Piccinin S, Doglioni C, Gasparotto D, Vukosavljevic T, Sulfaro S, Barzan L and Biocchi M. . 1996 Cancer Res. 56: 1146–1150.

  • Melamed J, Einhorn JM and Ittmann MM. . 1997 Clin. Cancer Res. 3: 1867–1872.

  • Mottaz AE, Markwalder R, Fey MF, Klima I, Merz VW, Thalmann GN, Ball RK and Studer UE. . 1997 Prostate 31: 209–215.

  • Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC and Conti CJ. . 1993 Natl. Cancer Inst. 85: 1657–1669.

  • Pearce SH, Trump D, Woodding C, Sheppard MN, Clayton RN and Thakker RV. . 1996 Clin. Endocrinol. 45: 195–200.

  • Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF and Prager D. . 1995 Cancer Res. 55: 1613–1616.

  • Phillips SM, Morton DG, Lee SJ, Wallace DM and Neoptolemos JP. . 1994 Br. J. Urol. 73: 390–395.

  • Salem CE, Tonasic NA, Elmajian DA, Esring D, Nichols PW, Taylor CR, Skinner DG, Roy-Burman P, Lieskovsky G and Cote RJ. . 1997 J. Urol. 158: 510–514.

  • Sarkar FH, Sakr W, Macoska J, Ball DE and Crissman JD. . 1992 Prostate 21: 145–152.

  • Sigurdsson S, Thorlaciius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjord JE and Jonsson E. . 1997 J. Mol. Med. 75: 758–761.

  • Steck PA, Pershouse MA, Jasser SA, Yung WAK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF and Tavtigian SV. . 1997 Nat. Genet. 15: 356–362.

  • Suzuki H, Emi M, Komiya A, Fujiwara Y, Yatani R, Nakamura Y and Shimazaki J. . 1995 Genes, Chromosomes Cancer 13: 168–174.

  • Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Issacs WB and Bova SG. . 1998 Cancer Res. 58: 204–209.

  • Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF and Goldgar DE. . 1996 Nat. Genet. 12: 333–337.

  • Teng DH-F, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WKA, Fujii G, Berson A, Bookstein R, Bolen JB, Tavtigian SV and Steck P. . 1997 Cancer Res. 57: 5221–5225.

  • Trapman J, Sleddens HFBM, van der Weiden MM, Dinjens WMM, Koning JJ, Schroder FH, Faber PW and Bosman FT. . 1994 Cancer Res. 54: 6061–6064.

  • Ueda T, Komiya A, Emi M, Suzuki H, Shiraishi T, Yatani R, Masai M, Yasuda K and Ito H. . 1997 Genes, Chromosomes Cancer 20: 140–147.

  • Visakorpi T, Kallioniemi AH, Syvanen AC, Hytinen ER, Karhu R, Tammela T, Isola JJ and Kallioniemi OP. . 1995 Cancer Res. 55: 342–347.

  • Weinberg RA. . 1991 Science 254: 1138–1146.

  • Weinstein IB. . 1996 J. Cell. Biochem. 25: 23–28. [Suppl].

  • Yoo GH, Xu HJ, Breennan JA, Westra W, Hruban RH, Koch W, Benedict WF and Sidransky D. . 1994 Cancer Res. 54: 4603–4606.

  • Zar JH. . 1991 Biostatistical Analysis. Prentice Hall: Englewood Cliffs, NJ.

    Google Scholar 

  • Zenklusen JC, Thompson JC, Troncoso P, Kagan J and Conti CJ. . 1995 Cancer Res. 54: 6370–6373.

Download references

Acknowledgements

This study was supported by NCI grant CA68578-01 (MR Spitz and J Kagan) and by the University of Texas MD Anderson Cancer Center Physician Referral Service Award (J Kagan).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yin, Z., Spitz, M., Babaian, R. et al. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Oncogene 18, 7576–7583 (1999). https://doi.org/10.1038/sj.onc.1203203

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203203

Keywords

This article is cited by

Search

Quick links